Mentions:
1: Lord Patel (CB - Life peer) instead of Euratom will be for nuclear research and will not be used for things such as manufacturing radioisotopes - Speech Link
Asked by: Darren Jones (Labour - Bristol North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the supply of (a) nuclear medications and (b) medical radioisotopes from EU member states.
Answered by Will Quince
We are not aware of any supply issues with nuclear medications or medical radioisotopes in the United Kingdom.
The Department’s medicine supply team works closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England and others to help prevent shortages and to ensure that the risks to patients are minimised when supply issues do arise.
Written Evidence Jun. 28 2023
Inquiry: Future cancerFound: six nuclear reactors along with a network of smaller cyclotron facilities largely supply all the radioisotopes
Mentions:
1: Liz Saville Roberts (PC - Dwyfor Meirionnydd) Medical radioisotopes are highly significant for the diagnosis and treatment of dangerous cancer cells - Speech Link
2: Liz Saville Roberts (PC - Dwyfor Meirionnydd) The Minister is of course aware of the proposal for a medical radioisotopes facility in north Wales, - Speech Link
3: Will Quince (CON - Colchester) Lady would write to me with the details, I will certainly raise the issue and meet to discuss radioisotopes - Speech Link
Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the (a) medium-term and (b) long-term sustainability of the supply of (i) Molybdenum-99 generators, (ii) Iodine-131medical grade radioisotopes and (iii) other medical grade radioisotopes.
Answered by Will Quince
We are working closely with officials in the Department for Energy Security and Net Zero who are leading a £6 million funded Medical Radionuclide Innovation Programme. This is focused on safeguarding the provision and development of radiopharmaceuticals for United Kingdom patients in the medium and long-term and encouraging innovation in technologies and techniques that could support access to radioisotopes in order to increase the UK’s resilience in times of global supply constraints or shortages. The Department for Energy Security and Net Zero has commissioned a landscape assessment to inform Government action in this area.
We routinely monitor short-term threats to the supply of medical grade radioisotopes, including through regular contact with UK suppliers, and has well-established processes which aim to prevent supply issues occurring in the first instance, and to manage or mitigate them when they occur. There are currently no active UK supply issues with medical radioisotopes.
Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the level of medical grade radioisotopes in the UK including (a) Molybdenum-99 generators and and (b) Iodine-131.
Answered by Will Quince
We are working closely with officials in the Department for Energy Security and Net Zero who are leading a £6 million funded Medical Radionuclide Innovation Programme. This is focused on safeguarding the provision and development of radiopharmaceuticals for United Kingdom patients in the medium and long-term and encouraging innovation in technologies and techniques that could support access to radioisotopes in order to increase the UK’s resilience in times of global supply constraints or shortages. The Department for Energy Security and Net Zero has commissioned a landscape assessment to inform Government action in this area.
We routinely monitor short-term threats to the supply of medical grade radioisotopes, including through regular contact with UK suppliers, and has well-established processes which aim to prevent supply issues occurring in the first instance, and to manage or mitigate them when they occur. There are currently no active UK supply issues with medical radioisotopes.
Aug. 08 2023
Source Page: Pioneering worldwide space partnerships to boost UK innovationFound: , Aerojet Rocketdyne, NASA Glenn Research Center, John Hopkins University (USA) Co-operation around radioisotopes
May. 30 2024
Source Page: I. Documents held by the Atomic Weapons Establishment relating to nuclear test veterans: includes technical reports, Government correspondence relating to the need to carry out precautionary testing, correspondence between the Atomic Weapons Research Establishment (AWRE) and the Veterans Agency relating to nuclear test veterans’ claims, an AWRE health and safety report, an aircraft decontamination report, a limited amount of blood and urine test data from a small number of personnel [redacted] (151 docs). II. Letter dated 20/05/2024 from Andrew Murrison MP to Rebecca Long Bailey MP and John Hayes MP regarding the declassification and publication on gov.uk of documents held by the Atomic Weapons Establishment (AWE) relating to nuclear test veterans. II.Found: Radioisotopes in drinking water, vegetation.
Written Evidence Jun. 28 2023
Inquiry: Future cancerFound: Investment is particularly needed into medical physics with expertise in radioisotopes and in nuclear
Mentions:
1: Liz Saville Roberts (PC - Dwyfor Meirionnydd) What are medical radioisotopes, and why are they important? - Speech Link
2: Amanda Solloway (CON - Derby North) Radionuclides, also known as radioisotopes, are vital to UK healthcare. - Speech Link